Consensus Report: Diabetes Performance Measures: Current Status and Future Directions
- Patrick J. O'Connor, MD, MPH1⇑,
- Noni L. Bodkin, PhD2,
- Judith Fradkin, MD3,
- Russell E. Glasgow, PhD4,
- Sheldon Greenfield, MD5,
- Edward Gregg, PhD6,
- Eve A. Kerr, MD, MPH7,
- L. Gregory Pawlson, MD, MPH8,
- Joseph V. Selby, MD, MPH9,
- John E. Sutherland, MD10,
- Michael L. Taylor, MD11 and
- Carol H. Wysham, MD12
- Corresponding author: Patrick J. O'Connor, .
Jump to section
- 1. What is the evidence that measuring quality, benchmarking, and providing feedback or incentives improve diabetes care?
- 2. What are the limitations, burdens, and consequences (intended or unintended) of diabetes quality measures as currently structured? Dichotomous quality measures based on thresholds for continuous variables.
- 3. What should be the role of shared decision making, patient preferences, and patient-reported data in quality measures?
- 4. What is the future of quality measurement in diabetes?
- 5. How can quality monitoring be integrated into population surveillance efforts?
- Conclusions and Recommendations
- Figures & Data
- Info & Metrics